fda warning letter glp-1 solution september 9 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Alarming rise in weight loss
Description
Trumper A, Trumper K, Horsch D
doi: 10.1016/j.jdiacomp.2022.108255
Thyroid Monitoring While on GLP-1 Therapy Patients starting semaglutide should have baseline TSH and free T4 levels drawn before beginning treatment
Great price
